| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |